Skip to content

Clinical trials

Phase 3 Lung Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 3 Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20033
20041
20052
20061
20081
20092
20101
20123
20133
20147
20154
20164
20171
20183
20194
20203
20211
20221
20232
20244
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated14
Recruiting10
Active, not recruiting2
Withdrawn2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca17
Novartis Pharmaceuticals4
United Therapeutics3
BioNTech SE2
InterMune2
Pfizer2
University of South Florida2
Vertex Pharmaceuticals Incorporated2
Adrian Hernandez1
Aeris Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases62
Respiratory Tract Diseases35
Lung Diseases, Obstructive20
Asthma18
Bronchial Diseases15
Pulmonary Disease, Chronic Obstructive9
Respiratory Tract Infections9
COVID-197
Coronavirus Infections6
Infections6

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.